V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20219205 | 20083534 | 1.63 | 56 | null | 2016-08-28 | 2016-08-31 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + IRINOTECAN | 101292156 |
| 20219207 | 20083535 | null | null | null | 2019-05-30 | 2019-06-09 | HCX | 02 | null | HCX | 101483905 |
| 20219210 | 20083536 | null | null | null | 2018-02-24 | 2018-03-14 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100046118 |
| 20219216 | 20083537 | null | null | null | 2018-03-21 | 2018-03-24 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101734591 |
| 20219218 | 20083538 | 1.62 | 101.1 | Curative (C) | 2017-12-20 | 2018-01-01 | ECarboX | 02 | null | HCX | 100364327 |
| 20219219 | 20083539 | 1.62 | 82.9 | null | null | 2018-12-19 | null | null | Y | HCX | 101328807 |
| 20219221 | 20083540 | 1.56 | 71.8 | null | null | 2016-07-31 | null | null | null | CISPLATIN + ETOPOSIDE | 100628264 |
| 20219224 | 20083541 | 1.77 | 95.7 | null | null | 2018-08-29 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100888185 |
| 20219229 | 20083542 | 1.65 | 80 | Palliative (P) | null | 2018-05-22 | null | null | N | LENVATINIB | 100407822 |
| 20219230 | 20083543 | 1.73 | 80 | Adjuvant (A) | 2017-11-15 | 2017-11-22 | Cape+Cisplatin+Trastuzumab Load | 02 | null | HCX | 101308545 |
| 20219233 | 20083545 | 1.62 | 94 | Palliative (P) | null | 2018-12-06 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100750294 |
| 20219241 | 20083546 | 1.73 | 84 | Palliative (P) | 2017-08-05 | 2017-08-17 | HCX (Cape + Cisp + Tras) - Load | 02 | N | HCX | 101756316 |
| 20219247 | 20083547 | null | null | null | 2017-09-21 | 2017-09-22 | Cisplatin + Etoposide po&iv 3 day | 02 | null | CISPLATIN + ETOPOSIDE | 101870031 |
| 20219251 | 20083549 | null | null | Curative (C) | 2018-03-28 | 2018-04-02 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101627434 |
| 20219253 | 20083550 | 1.65 | null | Palliative (P) | 2019-02-03 | 2019-02-04 | LENVATINIB | 02 | N | LENVATINIB | 100636679 |
| 20219254 | 20083551 | 1.67 | 85 | Adjuvant (A) | 2020-01-30 | 2020-02-05 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100690186 |
| 20219257 | 20083552 | 1.67 | 63.5 | Curative (C) | 2019-11-26 | 2019-11-27 | Cisplatin + Etoposide (3 day) | 02 | N | CISPLATIN + ETOPOSIDE | 100295655 |
| 20219261 | 20083553 | null | 78.3 | Palliative (P) | null | 2018-01-10 | null | null | null | CISPLATIN + ETOPOSIDE | 101318055 |
| 20219262 | 20083554 | null | 69 | null | 2017-05-25 | 2017-05-25 | null | null | null | LENVATINIB | 100529146 |
| 20219266 | 20083555 | 1.7 | 56.1 | Neo-adjuvant (N) | null | 2016-05-14 | null | null | N | CISPLATIN + ETOPOSIDE | 100529918 |
| 20219267 | 20083556 | null | null | null | 2017-04-11 | 2017-04-23 | null | null | null | LENVATINIB | 100271432 |
| 20219270 | 20083557 | 1.7 | 83.2 | Adjuvant (A) | null | 2019-06-18 | null | null | N | CISPLATIN + ETOPOSIDE | 101214843 |
| 20219272 | 20083558 | 1.69 | 59.9 | Palliative (P) | 2019-03-02 | 2019-03-12 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 100758030 |
| 20219275 | 20083559 | 1.52 | 71.9 | Curative (C) | 2017-06-30 | 2017-07-21 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN + RT | 101201446 |
| 20219279 | 20083560 | 1.72 | 42 | Neo-adjuvant (N) | null | 2016-04-01 | null | null | Y | CISPLATIN + ETOPOSIDE | 100912583 |
| 20219282 | 20083561 | null | 83 | Palliative (P) | 2018-09-28 | 2018-10-02 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101819045 |
| 20219286 | 20083562 | 1.7 | null | Neo-adjuvant (N) | 2016-08-30 | 2016-08-30 | ECarboX | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101796148 |
| 20219289 | 20083563 | null | null | null | null | 2019-12-04 | null | null | null | LENVATINIB | 101785562 |
| 20219290 | 20083564 | 1.6 | 98 | Palliative (P) | 2017-03-28 | 2017-04-07 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101059105 |
| 20219293 | 20083565 | 1.52 | 57 | Palliative (P) | null | 2020-03-20 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100227374 |
| 20219301 | 20083567 | 1.69 | 128 | Palliative (P) | 2017-07-03 | 2017-07-04 | ECarboX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100928019 |
| 20219302 | 20083568 | 1.68 | 38.4 | Palliative (P) | 2019-02-02 | 2019-02-14 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 100245340 |
| 20219303 | 20083569 | 1.68 | 99.4 | 03 | 2018-08-20 | 2018-08-23 | null | null | N | CAPECITABINE + IRINOTECAN | 101309556 |
| 20219306 | 20083571 | 0 | 53.5 | Neo-adjuvant (N) | 2016-07-14 | 2016-07-28 | CETUXIMAB + IRINOTECAN + MDG | N | Y | CETUXIMAB + IRINOTECAN + MDG | 100391387 |
| 20219311 | 20083572 | 1.67 | 79.5 | Neo-adjuvant (N) | 2017-09-29 | 2017-10-01 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100642884 |
| 20219315 | 20083573 | 1.73 | 0 | null | 2019-11-21 | 2019-11-21 | CISPLATIN + ETOPOSIDE | 02 | null | CISPLATIN + ETOPOSIDE | 100423954 |
| 20219316 | 20083574 | null | null | null | null | 2018-10-20 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101001516 |
| 20219317 | 20083575 | 1.44 | null | Neo-adjuvant (N) | null | 2016-05-06 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101420927 |
| 20219321 | 20083576 | 1.68 | 53.5 | Palliative (P) | 2019-05-11 | 2019-05-12 | null | null | N | CAPECITABINE + IRINOTECAN | 101580980 |
| 20219322 | 20083577 | null | null | null | 2018-06-12 | 2018-06-19 | null | null | null | HCX | 101850825 |
| 20219324 | 20083578 | null | null | null | 2018-02-08 | 2018-02-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + IRINOTECAN + MDG | 100894128 |
| 20219335 | 20083579 | 1.65 | 63 | Neo-adjuvant (N) | null | 2016-08-16 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100812155 |
| 20219336 | 20083580 | null | null | null | 2017-03-16 | 2017-03-23 | Capecitabine (21 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 101643824 |
| 20219340 | 20083582 | 1.59 | 74 | Palliative (P) | 2020-05-07 | 2020-05-07 | CAPECITABINE + MITOMYCIN + RT | N | N | CAPECITABINE + MITOMYCIN + RT | 101001856 |
| 20219341 | 20083583 | 1.64 | 84.9 | Palliative (P) | null | 2019-03-20 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100620329 |
| 20219351 | 20083584 | 1.69 | 91.6 | null | 2017-03-17 | 2017-03-19 | null | null | Y | LENVATINIB | 101564360 |
| 20219352 | 20083585 | null | null | null | 2018-05-15 | 2018-05-15 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | N | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100538032 |
| 20219360 | 20083587 | 1.82 | 69.8 | Palliative (P) | null | 2019-01-19 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101066685 |
| 20219361 | 20083588 | 1.69 | 64 | null | 2018-01-14 | 2018-01-16 | LENVATINIB | 02 | null | LENVATINIB | 100646542 |
| 20219366 | 20083589 | null | null | null | 2019-04-25 | 2019-05-06 | null | null | null | CAPECITABINE + IRINOTECAN | 100649220 |